Cancer charities have condemned a decision not to licence a drug being trialled in our region which extends the life of women suffering the advanced stages of breast cancer.
The National Institute for Clinical Excellence - or NICE - says the drug "Perjeeta" isn't cost effective.
Perjeeta is currently being tested on women through the Christie Hospital in Manchester - but it isn't routinely available on the NHS.
Cancer charities and women taking the drug want NICE to reconsider .
Ashley Derricott reports.
More top news
An ex-police officer who secretly filmed his sexual encounters with seven women has been jailed for three years.
Police are appealing for witnesses after thieves ripped a cash machine from a shop front in Preesall using a stolen fork-lift truck.
Cleaners at Manchester Airport are to stage a series of strikes in a dispute over pay.